These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 33326154

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.
    Yamaoka K, Kodama K, Kawaoka T, Kosaka M, Johira Y, Shirane Y, Miura R, Yano S, Murakami S, Amioka K, Naruto K, Ando Y, Kosaka Y, Uchikawa S, Uchida T, Fujino H, Nakahara T, Murakami E, Okamoto W, Yamauchi M, Miki D, Imamura M, Takahashi S, Nagao A, Chayama K, Aikata H.
    PLoS One; 2022; 17(1):e0262675. PubMed ID: 35041693
    [Abstract] [Full Text] [Related]

  • 3. Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma.
    Kirino S, Tsuchiya K, Kurosaki M, Kaneko S, Inada K, Yamashita K, Osawa L, Hayakawa Y, Sekiguchi S, Okada M, Wang W, Higuchi M, Takaura K, Maeyashiki C, Tamaki N, Yasui Y, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Izumi N.
    PLoS One; 2020; 15(4):e0231828. PubMed ID: 32310967
    [Abstract] [Full Text] [Related]

  • 4. Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma.
    Takahashi A, Moriguchi M, Seko Y, Ishikawa H, Yo T, Kimura H, Fujii H, Shima T, Mitsumoto Y, Ishiba H, Takashima H, Nagao Y, Jo M, Arai M, Hara T, Okajima A, Muramatsu A, Morita A, Yoshinami N, Nakajima T, Mitsuyoshi H, Umemura A, Nishikawa T, Yamaguchi K, Itoh Y.
    Anticancer Res; 2019 Sep; 39(9):5149-5156. PubMed ID: 31519627
    [Abstract] [Full Text] [Related]

  • 5. The Association Between Extracellular Water-to-Total Body Water Ratio and Therapeutic Durability for Advanced Lung Cancer.
    Noda Y, Suzuki H, Kanai T, Samejima Y, Nasu S, Tanaka A, Morishita N, Okamoto N, Hirashima T.
    Anticancer Res; 2020 Jul; 40(7):3931-3937. PubMed ID: 32620634
    [Abstract] [Full Text] [Related]

  • 6. Using dilution techniques and multifrequency bioelectrical impedance to assess both total body water and extracellular water at baseline and during recombinant human growth hormone (GH) treatment in GH-deficient adults.
    Janssen YJ, Deurenberg P, Roelfsema F.
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3349-55. PubMed ID: 9329367
    [Abstract] [Full Text] [Related]

  • 7. Extracellular Water-to-total Body Water Ratio as an Objective Biomarker for Frailty in Lung Cancer Patients.
    Hirashima T, Noda Y, Suzuki H, Nasu S, Tanaka A, Morishita N, Ryota N, Iwata K, Okada Y, Okamoto N.
    Anticancer Res; 2021 Mar; 41(3):1655-1662. PubMed ID: 33788762
    [Abstract] [Full Text] [Related]

  • 8. Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.
    Tada T, Kumada T, Hiraoka A, Michitaka K, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Yasuda S, Toyoda H, Fukunishi S, Ohama H, Kawata K, Nakamura S, Nouso K, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Joko K, Koizumi Y, Hiasa Y, Real-Life Experts for HCC (RELPEC) Study Group and the HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).
    Oncology; 2021 Mar; 99(8):518-527. PubMed ID: 33906189
    [Abstract] [Full Text] [Related]

  • 9. Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma.
    Ikeda K, Kudo M, Kawazoe S, Osaki Y, Ikeda M, Okusaka T, Tamai T, Suzuki T, Hisai T, Hayato S, Okita K, Kumada H.
    J Gastroenterol; 2017 Apr; 52(4):512-519. PubMed ID: 27704266
    [Abstract] [Full Text] [Related]

  • 10. The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib.
    Chihiro K, Kawaoka T, Uchikawa S, Kinami T, Yamasaki S, Kosaka M, Johira Y, Yano S, Amioka K, Naruto K, Ando Y, Yamaoka K, Teraoka Y, Uchida T, Fujino H, Nakahara T, Ono A, Murakami E, Okamoto W, Yamauchi M, Miki D, Tsuge M, Imamura M, Aikata H, Oka S.
    Oncology; 2023 Apr; 101(8):491-501. PubMed ID: 37429266
    [Abstract] [Full Text] [Related]

  • 11. Assessment of body composition using dry mass index and ratio of total body water to estimated volume based on bioelectrical impedance analysis in chronic kidney disease patients.
    Ohashi Y, Otani T, Tai R, Tanaka Y, Sakai K, Aikawa A.
    J Ren Nutr; 2013 Jan; 23(1):28-36. PubMed ID: 22406124
    [Abstract] [Full Text] [Related]

  • 12. Assessment of body water distribution in patients with sepsis during fluid resuscitation using multi-frequency direct segmental bioelectrical impedance analysis.
    Park I, Lee JH, Jang DH, Kim J, Hwang BR, Kim S, Lee JE, Jo YH.
    Clin Nutr; 2020 Jun; 39(6):1826-1831. PubMed ID: 31416662
    [Abstract] [Full Text] [Related]

  • 13. Extracellular water to total body water ratio may mediate the association between phase angle and mortality in patients with cancer cachexia: A single-center, retrospective study.
    Katsura N, Yamashita M, Ishihara T.
    Clin Nutr ESPEN; 2021 Dec; 46():193-199. PubMed ID: 34857195
    [Abstract] [Full Text] [Related]

  • 14. The prediction of total body water and extracellular water from bioelectric impedance in obese children.
    Bedogni G, Bollea MR, Severi S, Trunfio O, Manzieri AM, Battistini N.
    Eur J Clin Nutr; 1997 Mar; 51(3):129-33. PubMed ID: 9076401
    [Abstract] [Full Text] [Related]

  • 15. Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses.
    Tamai T, Hayato S, Hojo S, Suzuki T, Okusaka T, Ikeda K, Kumada H.
    J Clin Pharmacol; 2017 Sep; 57(9):1138-1147. PubMed ID: 28561918
    [Abstract] [Full Text] [Related]

  • 16. Altered body water distribution in subjects with juvenile rheumatoid arthritis and its effects on the measurement of water compartments from bioelectric impedance.
    Bedogni G, Polito C, Severi S, Strano CG, Manzieri AM, Alessio M, Iovene A, Battistini N.
    Eur J Clin Nutr; 1996 Jun; 50(6):335-9. PubMed ID: 8793411
    [Abstract] [Full Text] [Related]

  • 17. Extracellular Water to Total Body Water Ratio in Viral Liver Diseases: A Study Using Bioimpedance Analysis.
    Nishikawa H, Yoh K, Enomoto H, Ishii N, Iwata Y, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Hasegawa K, Takashima T, Iijima H, Nishiguchi S.
    Nutrients; 2018 Aug 12; 10(8):. PubMed ID: 30103528
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of 8 weeks' relative dose intensity of lenvatinib in treatment of radioiodine-refractory differentiated thyroid cancer patients.
    Fukuda N, Toda K, Wang X, Ohmoto A, Hayashi N, Urasaki T, Sato Y, Nakano K, Ono M, Tomomatsu J, Mitani H, Takahashi S.
    Endocr J; 2021 Jun 28; 68(6):639-647. PubMed ID: 33504716
    [Abstract] [Full Text] [Related]

  • 19. Body water distribution in severe obesity and its assessment from eight-polar bioelectrical impedance analysis.
    Sartorio A, Malavolti M, Agosti F, Marinone PG, Caiti O, Battistini N, Bedogni G.
    Eur J Clin Nutr; 2005 Feb 28; 59(2):155-60. PubMed ID: 15340370
    [Abstract] [Full Text] [Related]

  • 20. C-reactive protein can predict dose intensity, time to treatment failure and overall survival in HCC treated with lenvatinib.
    Hayashi T, Shibata M, Oe S, Miyagawa K, Honma Y, Harada M.
    PLoS One; 2020 Feb 28; 15(12):e0244370. PubMed ID: 33351844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.